Metastases to the pituitary gland are a rare finding, with breast and lung being the most common metastases in this anatomical region. Pituitary melanoma metastases reports are thus sparse, and both diagnosis and treatment are challenging. We present the case of a 66-year-old woman with pituitary melanoma metastasis who presented with symptoms of anterior pituitary dysfunction and headache. These symptoms were difficult to manage medically until gross total resection and immunotherapy were carried out. At 17 months post-operative, there was no progression of the underlying disease. A review of the published literature was performed for all the histologically confirmed pituitary melanoma metastases, as well as their clinical presentation, diagnosis, and treatment workout. Our literature review included 18 published cases: the median age was 62, 68% were male, and the median time of melanoma diagnosis to pituitary metastasis diagnosis was 25 months. The most common symptoms were anterior pituitary deficiency, visual disturbances, headache, cranial nerve palsy, and diabetes insipidus. In terms of management, surgery, radiotherapy, and chemotherapy were used alone or in combination. The median overall survival was 9.5 months. These metastases present a great diagnostic and therapeutic challenge since the symptoms are non-specific and there are no available treatment guidelines. Surgery to decompress the adjacent structures allows for symptomatic control and a better quality of life.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753814PMC
http://dx.doi.org/10.7759/cureus.76266DOI Listing

Publication Analysis

Top Keywords

pituitary melanoma
16
pituitary
8
melanoma metastasis
8
literature review
8
melanoma metastases
8
diagnosis treatment
8
symptoms anterior
8
anterior pituitary
8
metastases
5
metastasis case
4

Similar Publications

Metastases to the pituitary gland are a rare finding, with breast and lung being the most common metastases in this anatomical region. Pituitary melanoma metastases reports are thus sparse, and both diagnosis and treatment are challenging. We present the case of a 66-year-old woman with pituitary melanoma metastasis who presented with symptoms of anterior pituitary dysfunction and headache.

View Article and Find Full Text PDF

Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study.

EClinicalMedicine

January 2025

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Background: Due to limited data on managing immunotherapy-induced secondary adrenal insufficiency (SAI) in melanoma survivors, this study investigated its management strategies and outcomes.

Methods: This retrospective cohort study analyzed melanoma patients treated with immune checkpoint inhibitors (ICIs) with SAI (Mel_SAI, n = 161), without SAI (Mel_CON, n = 168), and patients with pituitary adenoma-related SAI (Pit_SAI, n = 106) at our institution from January 2013 to November 2023. We compared glucocorticoid management patterns, quality of life using distress scores, and the impact of different glucocorticoid types on survival outcomes using Kaplan-Meier analysis.

View Article and Find Full Text PDF
Article Synopsis
  • - Immune checkpoint inhibitors, like pembrolizumab used in melanoma treatment, can cause rare autoimmune reactions affecting endocrine glands, leading to conditions like hyperthyroidism and hypothyroidism.
  • - A 39-year-old man experienced a sequence of endocrine issues following his pembrolizumab treatment, including thyrotoxicosis, hypothyroidism, and central adrenal insufficiency.
  • - This case highlights the need for careful monitoring of hormonal functions in patients undergoing immunotherapy due to the variability and unusual nature of these endocrine side effects.
View Article and Find Full Text PDF

 The lateral supraorbital (LSO) approach is a less-invasive alternative to the pterional craniotomy that provides rapid transsylvian access. Establishing familiarity with the LSO technique and its features as compared with other anterolateral approaches is an important component of advanced skull base training. We present a step-by-step demonstration of the LSO approach using cadaveric dissection in a manner that is digestible for trainees at various levels.

View Article and Find Full Text PDF

Immune checkpoint inhibitors, such as pembrolizumab, have transformed cancer therapy by enhancing the immune system's ability to combat tumors, but they can also lead to immune-related adverse events, including adrenal insufficiency. This case report presents a 52-year-old male with a history of malignant melanoma who developed adrenal insufficiency after four months of pembrolizumab therapy. The patient was admitted with symptoms of malaise, vomiting, abdominal pain, and poor appetite.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!